Loading…

Examining the implications of drug importation hearing before the Committee on the Judiciary, United States Senate, One Hundred Eighth Congress, second session, July 14, 2004.

Saved in:
Bibliographic Details
Corporate Author: United States. Congress. Senate. Committee on the Judiciary
Format: Government Document Microfilm Book
Language:English
Published: Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2008.
Series:S. hrg. ; 108-923.
Physical Description:
iv, 278 pages : illustrations ; 24 cm.
Subjects:

MARC

LEADER 00000nam a2200000 a 4500
001 ocn403873360
003 OCoLC
005 20100227134109.2
007 he bmb024bbca
008 090619s2008 dcua bb f000 0 eng c
035 |a (OCoLC)403873360 
037 |a 552-070-38168-6  |b GPO  |f paper 
040 |a GPO  |b eng  |c GPO 
042 |a pcc 
043 |a n-us--- 
049 |a COM4 
050 1 4 |a KF26  |b .J8 2004w 
074 |a 1042-B (MF) 
086 0 |a Y 4.J 89/2:S.HRG.108-923 
088 |a Serial no. J-108-89 (United States. Congress. Senate. Committee on the Judiciary) 
110 1 |a United States.  |b Congress.  |b Senate.  |b Committee on the Judiciary.  |0 https://id.loc.gov/authorities/names/n82209587. 
245 1 0 |a Examining the implications of drug importation  |h [microform] :  |b hearing before the Committee on the Judiciary, United States Senate, One Hundred Eighth Congress, second session, July 14, 2004. 
264 1 |a Washington :  |b U.S. G.P.O. :  |b For sale by the Supt. of Docs., U.S. G.P.O.,  |c 2008. 
300 |a iv, 278 pages :  |b illustrations ;  |c 24 cm. 
336 |a text  |b txt  |2 rdacontent. 
337 |a microform  |b h  |2 rdamedia. 
338 |a microfiche  |b he  |2 rdacarrier. 
490 1 |a S. hrg. ;  |v 108-923. 
500 |a Shipping list no.: 2009-0164-P. 
504 |a Includes bibliographical references. 
500 |a "Serial no. J-108-89." 
533 |a Microfiche.  |b [Washington, D.C.] :  |c Supt. of Docs., U.S. G.P.O.,  |d [2009]  |e 3 microfiches : negative. 
650 0 |a Drug reimportation  |0 https://id.loc.gov/authorities/subjects/sh2005001953  |z United States.  |0 https://id.loc.gov/authorities/names/n78095330-781. 
650 0 |a Product counterfeiting  |z United States.  |0 https://id.loc.gov/authorities/subjects/sh2010106475. 
650 0 |a Imports  |0 https://id.loc.gov/authorities/subjects/sh87004893  |x Law and legislation  |0 https://id.loc.gov/authorities/subjects/sh99004848  |z United States.  |0 https://id.loc.gov/authorities/names/n78095330-781. 
650 0 |a Consumer protection  |z United States.  |0 https://id.loc.gov/authorities/subjects/sh2008100017. 
650 0 |a Foreign trade regulation  |z United States.  |0 https://id.loc.gov/authorities/subjects/sh85050533. 
650 0 |a Pharmaceutical policy  |z United States.  |0 https://id.loc.gov/authorities/subjects/sh2008109173. 
776 1 |a United States. Congress. Senate. Committee on the Judiciary.  |t Examining the implications of drug importation  |h iv, 278 p.  |w (OCoLC)274128841. 
776 1 |a United States. Congress. Senate. Committee on the Judiciary.  |t Examining the implications of drug importation  |h iv, 278 p.  |w (OCoLC)271655708. 
810 1 |a United States.  |b Congress.  |b Senate.  |t S. hrg. ;  |0 https://id.loc.gov/authorities/names/n83707917  |v 108-923. 
907 |a .b29310726  |b cug   |c -  |d 091125  |e 230523 
998 |a cug  |b 100227  |c m  |d a   |e -  |f eng  |g dcu  |h 0  |i 0 
948 |a MARCIVE Comp, in 2022.12 
948 |a MARCIVE August, 2017 
948 |a MARCIVE extract Aug 5, 2017 
994 |a 92  |b COM 
995 |a Loaded with m2btab.ltiac in 2022.12 
995 |a Loaded with m2btab.ltiac in 2017.08 
995 |a OCLC offline update by CMU 
989 |a Y 4.J 89/2:S.HRG.108-923  |d cusgh  |e  - -   |f  - -   |g -   |h 0  |i 0  |j 67  |k 091125  |l $0.00  |m    |n  - -   |o -  |p 0  |q 0  |t 0  |x 0  |1 .i55895931 
989 |a Y 4.J 89/2:S.HRG.108-923  |d cusgh  |e  - -   |f  - -   |g -   |h 0  |i 0  |j 67  |k 100227  |l $0.00  |m    |n  - -   |o -  |p 0  |q 0  |t 0  |x 0  |1 .i5670043x